Venture Certified
| 연구개발유형 | 2020-03-03 ~ 2022-03-02 | 20200102295 | 2020-03-03 |
| 연구개발유형 | 2022-03-03 ~ 2025-03-02 | 20220316020006 | 2020-03-03 |
| 연구개발유형 | 2025-03-03 ~ 2028-03-02 | 20250225020009 | 2020-03-03 |
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 0.0B | 0.0B |
| Operating Profit | -33B | -18B |
| Net Profit | -33B | -18B |
| Total Assets | 6.8B | 5.4B |
| Total Liabilities | 35B | 20B |
| Total Equity | -28B | -15B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -33B
2 Consecutive Years of Net Loss
- 0.0%
▼ 81.7%
▲ 9.3%
▼ 6.0%
| Name | Position | Role |
|---|---|---|
| 이득원 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 송파구",
"ceo_name": "이득원",
"certificate": [
{
"cert_number": "20200102295",
"changes": "",
"disclosure_date": "2020-03-03",
"first_cert_date": "2020-03-03",
"no": "1",
"type": "연구개발유형",
"valid_period": "2020-03-03 ~ 2022-03-02"
},
{
"cert_number": "20220316020006",
"changes": "",
"disclosure_date": "2022-03-16",
"first_cert_date": "2020-03-03",
"no": "2",
"type": "연구개발유형",
"valid_period": "2022-03-03 ~ 2025-03-02"
},
{
"cert_number": "20250225020009",
"changes": "",
"disclosure_date": "2025-02-25",
"first_cert_date": "2020-03-03",
"no": "3",
"type": "연구개발유형",
"valid_period": "2025-03-03 ~ 2028-03-02"
}
],
"company_name": "파로스젠 주식회사",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 361150000,
"cost_of_sales": 0,
"current_assets": 374912000,
"current_liabilities": 1125312000,
"gross_profit": 0,
"net_income": -1846479000,
"net_income_bs": -1846479000,
"non_current_assets": 167010000,
"non_current_liabilities": 867602000,
"non_operating_expenses": 53938000,
"non_operating_income": 3866000,
"operating_profit": -1796407000,
"revenue": 0,
"sga_expenses": 1796407000,
"total_assets": 541922000,
"total_equity": -1450991000,
"total_liabilities": 1992914000
},
"2023": {
"capital_stock": 372036000,
"cost_of_sales": 0,
"current_assets": 501660000,
"current_liabilities": 2533211000,
"gross_profit": 0,
"net_income": -3324288000,
"net_income_bs": -3324288000,
"non_current_assets": 179787000,
"non_current_liabilities": 926540000,
"non_operating_expenses": 61592000,
"non_operating_income": 524000,
"operating_profit": -3263220000,
"revenue": 0,
"sga_expenses": 3263220000,
"total_assets": 681447000,
"total_equity": -2778303000,
"total_liabilities": 3459751000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "신약연구개발,판매",
"phone": "02-549-****",
"years": [
2023,
2022
]
}Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 6/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |